News|Articles|August 1, 2025
How One Brand Protected Market Share Amid Biosimilar Pressure
Case study on how one mature/late stage biopharmaceutical brand leveraged SamaCare’s insights and intervention platform to decrease administrative related discontinuations of their drug and maintain market share during a biosimilar release.
Related Content
Trending on PharmExec
1
The Agentic AI Revolution in Biopharma
2
How Cortisol-Targeted Approaches Might be Paired with GLP-1 Medications
3
Novartis Investors Share Concerns Over M&A Strategy: Report
4
Artisan Partners’ Director Calls for Novartis Board Shake-Up
5